Press Releases

MYOS RENS enters into agreement with Kansas State University to study impact of Fortetropin® on reducing muscle loss in dogs after joint surgery
MYOS RENS Technology to host April 4 interactive conference call on "Qurr" product launch
Are you Qurr-ious? MYOS Rens Technology Inc. Launches Qurr Product Line Powered by Fortetropin®, an All-Natural Ingredient Clinically Proven to Increase Muscle Size and Mass
'Qurr' line of revolutionary muscle-health and muscle-building products in newly-enhanced form set for March rollout
MYOS RENS Technology Inc. Adopts Shareholder Rights Plan
MYOS RENS Technology Inc. Announces $2,125,000 Registered Direct Offering
Dr. Robert Hariri, stem cell pioneer and chairman of MYOS RENS Technology, states that 'healthy muscle is key to overall health and wellness'
MYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript
MYOS RENS Technology Inc. Appoints Joseph Mannello as Interim Chief Executive Officer
MYOS Reports Positive Results From Fortetropin(R) Clinical Study
RSS
Show All